|
|
Other links at Articles > Allergy and Clinical Immunology |
| 4. |
Non-Aluminum Adjuvant Boosts Immunogenicity of H5N1 Flu Vaccine
|
|
|
MF59, an oil-in-water emulsion adjuvant approved since 1997 by several European countries for use in seasonal influenza vaccines, increases the immunogenicity of an H5N1 avian influenza vaccine, according to a study reported in the March 1 issue of the Journal of Infectious Diseases. Reuters Health Information
|
| 5. |
Omalizumab Cost-Effective for Severe Persistent Allergic Asthma
|
|
|
The anti-IgE antibody omalizumab is cost-effective for treating patients with severe persistent allergic asthma despite high-dose inhaled corticosteroid (ICS) plus a long-acting beta-2-agonist (LABA), according to a report in the June issue of Allergy. Reuters Health Information
|
|
|